We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $579M
1-Year Est. Return 94.36%
This Fund
S&P 500
This Quarter Est. Return
-1.54%
1 Year Est. Return
+94.36%
3 Year Est. Return
+196.81%
5 Year Est. Return
+210.19%
10 Year Est. Return
–
AUM
$479M
AUM Growth
-$5.04M
Cap. Flow
+$8.34M
Cap. Flow %
1.74%
Top 10 Hldgs %
67.05%
Holding
98
New
1
Increased
4
Reduced
1
Closed
5

Top Buys

1
PROK icon
ProKidney
PROK
+$17.4M
2
GPGI
GPGI Inc
GPGI
+$3.2M
3
TCDA
Tricida, Inc. Common Stock
TCDA
+$547K
4
ONDS icon
Ondas Inc
ONDS
+$436K
5
LIQT icon
LiqTech
LIQT
+$267K

Top Sells

1
ISLE
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
+$9.96M
2
FAZE
FaZe Holdings Inc. Common Stock
FAZE
+$2.24M
3
TEKK
Tekkorp Digital Acquisition Corp. Class A Ordinary Shares
TEKK
+$990K
4
SVRE
SaverOne 2014 Ltd
SVRE
+$272K
5
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$31.2K

Sector Composition

1 Healthcare 21.66%
2 Consumer Discretionary 16.65%
3 Industrials 15.31%
4 Financials 13.16%
5 Materials 7.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLD icon
1
SPDR Gold Trust
GLD
$129B
$73.5M 15.33%
475,000
– –
BC icon
2
Brunswick
BC
$5.33B
$63.9M 13.32%
975,636
– –
LIN icon
3
Linde
LIN
$241B
$34.7M 7.23%
128,564
– –
INVE icon
4
Identive
INVE
$68.1M
$33M 6.89%
2,634,495
– –
IVAC
5
DELISTED
Intevac Inc
IVAC
$23M 4.8%
4,944,105
– –
CTIC
6
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$23M 4.79%
3,943,730
-5,000
-0.1% -$31.2K
PACX
7
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$21.2M 4.42%
2,125,000
– –
PROK icon
8
ProKidney
PROK
$330M
$18M 3.76%
+2,000,000
New +$17.4M
THO icon
9
Thor Industries
THO
$4.03B
$15.9M 3.32%
227,500
– –
DRRX
10
DELISTED
DURECT Corp
DRRX
$15.3M 3.19%
2,641,466
– –
GPGI
11
GPGI Inc
GPGI
$4.32B
$14.7M 3.07%
3,531,746
+681,891
+24% +$3.2M
OPTN
12
DELISTED
OptiNose
OPTN
$13.8M 2.89%
252,132
– –
MDXH icon
13
MDxHealth
MDXH
$21.9M
$13.2M 2.76%
1,958,333
– –
CORS
14
DELISTED
Corsair Partnering Corporation
CORS
$12.2M 2.55%
1,250,000
– –
SPGI icon
15
S&P Global
SPGI
$135B
$12.2M 2.55%
40,000
– –
LSXMK
16
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$8.91M 1.86%
305,187
– –
MRNS
17
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$8.79M 1.83%
1,322,463
– –
BX icon
18
Blackstone
BX
$158B
$6.7M 1.4%
80,000
– –
TV icon
19
Televisa
TV
$1.42B
$5.38M 1.12%
1,000,000
– –
TCDA
20
DELISTED
Tricida, Inc. Common Stock
TCDA
$5.24M 1.09%
500,000
+50,000
+11% +$547K
IDN icon
21
Intellicheck
IDN
$75.9M
$5.22M 1.09%
2,073,583
– –
DUOT icon
22
Duos Technologies
DUOT
$266M
$5.21M 1.09%
1,283,162
– –
MIST icon
23
Milestone Pharmaceuticals
MIST
$154M
$4.71M 0.98%
512,500
– –
AENT icon
24
Alliance Entertainment
AENT
$293M
$3.98M 0.83%
400,000
– –
LSXMA
25
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$3.94M 0.82%
141,002
– –
1
2 3 4

Similar funds

BCM
Bourgeon Capital Management Darien, Connecticut $578M AUM 41.69% 1-Year Est. Return
LRIA
Leonard Rickey Investment Advisors Yakima, Washington $578M AUM 16.23% 1-Year Est. Return
WCCM
Webs Creek Capital Management Dallas, Texas $578M AUM 79.84% 1-Year Est. Return
MIOT
Massachusetts Institute of Technology Cambridge, Massachusetts $577M AUM 8.5% 1-Year Est. Return
AF
Aegis Financial Mc Lean, Virginia $580M AUM 105.74% 1-Year Est. Return
JCP
JB Capital Partners Armonk, New York $581M AUM 46.16% 1-Year Est. Return
GCM
Gibraltar Capital Management Tulsa, Oklahoma $581M AUM 18.65% 1-Year Est. Return
KNW
Kesler Norman & Wride Ogden, Utah $581M AUM 17.6% 1-Year Est. Return

Bleichroeder LP's Q3 2022 Portfolio in Review

As of Q3 2022, Bleichroeder LP held 98 positions worth $479M, down 1% from $484M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Bleichroeder LP's Q3 2022 filing shows 1 new, 4 increased, 1 reduced and 5 closed positions. Its largest new stake was ProKidney: 2,000,000 shares worth $18M. The largest sale was Isleworth Healthcare Acquisition Corporation Common stock, an estimated $9.96M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bleichroeder LP's largest Q3 2022 buy was ProKidney: 2,000,000 shares worth $18M.
  • Bleichroeder LP added most to GPGI Inc in Q3 2022, an estimated $3.2M increase.
  • Bleichroeder LP's biggest Q3 2022 reduction was CTI BioPharma Corp. (DE) Common Stock, cutting an estimated $31.2K.
  • Bleichroeder LP fully exited Isleworth Healthcare Acquisition Corporation Common stock in Q3 2022, selling an estimated $9.96M.
  • Bleichroeder LP's ten largest holdings make up 67% of its $479M portfolio in Q3 2022.
  • Bleichroeder LP opened 1 new position and closed 5 in Q3 2022.
  • Bleichroeder LP's portfolio value fell 1% quarter-over-quarter to $479M.

Based on Bleichroeder LP's 13F filing for Q3 2022, filed 14 Nov 2022.